Inactive Instrument

Analyst Reco. RedHill Biopharma Ltd TEL AVIV STOCK EXCHANGE

Equities

Redhill Biopharma Says Opaganib Cuts Mortality Rates by 70.2% in Severe COVID-19 Patients	22-02-07	MT
Ascendiant Capital Adjusts Price Target on Redhill Biopharma to $19 From $26, Maintains Buy Rating	21-12-27	MT
Ladenburg Thalmann Adjusts Redhill Biopharma's Price Target to $9 from $21, Maintains Buy Rating	21-12-01	MT
REDHILL BIOPHARMA : HC Wainwright Trims Redhill Biopharma's Price Target to $21 From $23, Keeps Buy Rating	21-09-15	MT
Redhill Biopharma : Shares Climb after Cantor Fitzgerald Initiates Coverage With Overweight Rating	21-08-31	MT
Today on Wall Street: US tech giants return to top spot	21-08-31
ANALYST RECOMMENDATIONS : AT&T, BancorpSouth Bank, CMO Group, Magnite, Textron...	21-08-31
REDHILL BIOPHARMA : Cantor Fitzgerald Starts Redhill Biopharma at Overweight With $22 Price Target	21-08-31	MT
REDHILL BIOPHARMA : WBB Securities Downgrades Redhill Biopharma to Buy Rating From Strong Buy	21-05-28	MT
REDHILL BIOPHARMA : HC Wainwright Starts Redhill Biopharma at Buy With $23 Price Target	21-05-18	MT

No results for this search